Abnormal clotting in cancer: An overview of pathophysiology and etiology

Seminars in Oncology Nursing

Volumn 21, Issue 4 SUPPL. 1, 2005, Pages 12-20

  Viale, Pamela Hallquist ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Camino Medical Group   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29144448786     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2005.10.013     Document Type: Article

References (36)

1. M. De Cicco The prothrombotic state in cancer Pathogenic mechanisms Crit Rev Oncol Hematol 50 2004 187 196
2. S. Gao, C. Escalante Venous thromboembolism and malignancy Expert Rev Anticancer Ther 4 2004 303 320
3. A. Falanga, A. Vignoli Venous thromboembolism in oncology Exp Oncol 26 2004 11 14
4. A.Y. Lee Management of thrombosis in cancer primary prevention and secondary prophylaxis Br J Haematol 128 2005 291 302
5. A.K. Kakkar Thrombosis and cancer Hematol J 3 suppl 5 2004 20 23
6. S.R. Deitcher Cancer-related deep venous thrombosis Clinical importance, treatment challenges, and management strategies Semin Thromb Hemost 3 2003 247 258
7. H.C. Kwaan, S. Parmar, J. Wang Pathogenesis of increased risk of thrombosis in cancer Semin Thromb Hemost 29 2003 283 290
8. K.E. Goad, H.R. Gralnick Coagulation disorders in cancer Hematol Compl Cancer 10 1996 457 471
9. A. Falanga, M. Marchetti, A. Vignoli Clotting mechanisms and cancer Implications in thrombus formation and tumor progression Clin Adv Hematol Oncol 1 2003 669 674
10. A. Piccioli, P. Prandoni, B.M. Ewenstein Cancer and venous thromboembolism Am Heart J 13 1996 850 855
11. S.R. Deitcher, M.P.V. Gomes Hypercoagulable state testing and malignancy screening following venous thromboembolic events Vascular Med 8 2003 33 46
12. P.M. Fernandez, S.R. Patierno, F.R. Rickles Tissue factor and fibrin in tumor angiogenesis Semin Thromb Hemost 30 2004 31 44
13. I. Gouin-Thibault, A. Achkar, M.M. Samama The thrombophilic state in cancer patients Acta Haematologica 106 2001 33 42
14. P. Prandoni, A. Falanga, A. Piccioli Cancer and venous thromboembolism Lancet Oncol 6 2005 401 410
15. R. Van Gerpen, M.E. Mast Thromboembolic disorders in cancer Clin J Oncol Nurs 8 2004 289 299
16. M. Levi Therapeutic options in patients with DIC and cancer Pathophysiology of Haemost Thromb 33 suppl 1 2003 46 47
17. S. Eichiger, K.A. Bauer Cancer-related coagulopathic complications R.D. Bast D.W. Kufe R.E. Pollack Cancer Medicine Ed 5. 2000 B. C. Decker Hamilton, Ontario
18. A.P. Barger, R. Hurley Evaluation of the hypercoagulable state. Whom to screen, how to test and treat Postgrad Med 108 2000 59 66 quiz, 17
19. Bauer KA: When to do a "hypercoagulable workup." Hematologist Mini-Review, Am Soc Hematol 2005. Available at: http://www.hematology.org/ publications/hematologist/jfm04/review.cfm (accessed Nov 7, 2005).
20. M. Verso, G. Agnelli Venous thromboembolism associated with long-term use of central venous catheters in cancer patients J Clin Oncol 21 2003 3665 3675
21. M.M. Bern, J.J. Lokich, S.R. Wallach Very low doses of warfarin can prevent thrombosis in central venous catheters A randomized prospective trial Ann Intern Med 112 1990 423 428
22. K. Carr, I. Rabinowitz Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors J Clin Oncol 18 2000 3665 3667
23. D.J. Kuter Thrombotic complications of central venous catheters in cancer patients Oncologist 9 2004 207 216
24. M. Verso, G. Agnelli, S. Bertoglio Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter A double-blind, placebo-controlled, randomized study in cancer patients J Clin Oncol 23 2005 4057 4062
25. L.T. Goodnough, H. Saito, A. Manni Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen Cancer 54 1984 1264 1268
26. I.I.I. Rogers JS, A.J. Murgo, J.A. Fontana Chemotherapy for breast cancer decreases plasma protein C and protein S J Clin Oncol 6 1988 276 281
27. S.R. Deitcher, M.P.V. Gomes The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma A systematic review Cancer 101 2004 439 449
28. P. Mehta, M. Hussein Thalidomide as anti-inflammatory therapy for multiple myeloma Leukemia 17 2003 2237 2238
29. M.A. Dimopoulos, V. Eleutherakis-Papaiakovou Adverse effects of thalidomide administration in patients with neoplastic diseases Am J Med 117 2004 508 515
30. T. Kuzel, B. Esparaz, D. Green Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin Cancer 65 1990 885 889
31. M.A. Shah, D. Ilson, D.P. Kelsen Thromboembolic events in gastric cancer High incidence in patients receiving irinotecan and bevacizumab based therapy J Clin Oncol 23 2005 2574 2576
32. C. Bokemeyer, M.S. Aapro, A. Courdi EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer Eur J Cancer 40 2004 2201 2216
33. A.Y.Y. Lee, M.N. Levine, R.I. Baker Low molecular weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 2003 146 153
34. L.R. Zacharski, P. Prandoni, M. Monreal Warfarin versus low-molecular-weight heparin therapy in cancer patients Oncol 10 2005 72 79
35. M. Altinbas, H.S. Coskun, O. Er A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer J Thromb Haemost 2 2004 1266 1271
36. C.P. Klerk, S.M. Smorenburg, H.M. Otten The effect of low molecular weight heparin on survival in patients with advanced malignancy J Clin Oncol 23 2005 2130 2135